Daniel Sullivan Appointed to Leadership Position in Acetaminophen MDL

New York—Holwell Shuster & Goldberg LLP partner Daniel Sullivan was recently appointed by Judge Denise Cote of the Southern District of New York to serve as plaintiffs’ liaison counsel in a high-profile multi-district litigation alleging that pregnant women’s prenatal use of acetaminophen, such as Tylenol, caused autism and ADHD in their children. He will be a member of the Plaintiffs’ Executive Committee and will chair the Administrative Functions & Common Benefit Reporting Subcommittee.

Dan brings significant litigation experience to this leadership team, often playing a leading role in significant litigation matters in courts across the country, including participating in HSG’s liaison counsel role in numerous RMBS putback actions consolidated in New York Supreme Court and HSG’s role as nationwide trial counsel to a major insurer in insurance coverage litigation arising out of opioid litigation. Before entering private practice, he served as a law clerk to the Honorable Antonin Scalia of the U.S. Supreme Court and to the Honorable Diarmuid F. O’Scannlain of the U.S. Court of Appeals for the Ninth Circuit.

The litigation, which is among the most closely watched mass torts in the country given its potential size, is In re Acetaminophen – ASD-ADHD Products Liability Litigation.